Junk science on the menu: How ‘Fat Studies’ endangers public health

Published



In Focus delivers deeper coverage of the political, cultural, and ideological issues shaping America. Published daily by senior writers and experts, these in-depth pieces go beyond the headlines to give readers the full picture. You can find our full list of In Focus pieces here.

The Wall Street Journal reported in August that fat activists, people who advocate to eliminate the social stigmas faced by fat people, are attacking Ozempic, the anti-obesity drug, for fueling the perception that fatness is a disorder instead of a harmless difference.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.